- Home
- ARW vs GRFS Comparison
ARW vs GRFS Comparison
Compare ARW & GRFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARW
- GRFS
- Stock Information
- Founded
- ARW 1935
- GRFS 1940
- Country
- ARW United States
- GRFS Spain
- Employees
- ARW N/A
- GRFS N/A
- Industry
- ARW Electronic Components
- GRFS Biotechnology: Pharmaceutical Preparations
- Sector
- ARW Technology
- GRFS Health Care
- Exchange
- ARW Nasdaq
- GRFS Nasdaq
- Market Cap
- ARW 5.9B
- GRFS 5.5B
- IPO Year
- ARW N/A
- GRFS 2006
- Fundamental
- Price
- ARW $116.70
- GRFS $7.27
- Analyst Decision
- ARW Hold
- GRFS Strong Sell
- Analyst Count
- ARW 4
- GRFS 1
- Target Price
- ARW $121.75
- GRFS N/A
- AVG Volume (30 Days)
- ARW 437.4K
- GRFS 704.7K
- Earning Date
- ARW 02-06-2025
- GRFS 01-01-0001
- Dividend Yield
- ARW N/A
- GRFS N/A
- EPS Growth
- ARW N/A
- GRFS N/A
- EPS
- ARW 8.98
- GRFS 0.27
- Revenue
- ARW $28,489,604,000.00
- GRFS $7,814,096,584.00
- Revenue This Year
- ARW N/A
- GRFS $9.31
- Revenue Next Year
- ARW $2.09
- GRFS $7.44
- P/E Ratio
- ARW $12.98
- GRFS $31.76
- Revenue Growth
- ARW N/A
- GRFS 7.21
- 52 Week Low
- ARW $108.51
- GRFS $5.30
- 52 Week High
- ARW $137.80
- GRFS $9.96
- Technical
- Relative Strength Index (RSI)
- ARW 54.30
- GRFS 43.85
- Support Level
- ARW $110.61
- GRFS $7.00
- Resistance Level
- ARW $113.05
- GRFS $7.53
- Average True Range (ATR)
- ARW 2.36
- GRFS 0.24
- MACD
- ARW 0.61
- GRFS -0.01
- Stochastic Oscillator
- ARW 99.44
- GRFS 27.00
About ARW Arrow Electronics Inc.
Arrow Electronics Inc. is a provider of products, services, and solutions to industrial and commercial users of electronic components and enterprise computing solutions. It has one of the world's broadest portfolios of product offerings available from electronic components and enterprise computing solutions suppliers, coupled with a range of services, solutions, and software, the company helps industrial and commercial customers introduce products, reduce their time to market, and enhance their overall competitiveness. The company has two business segments, the components business and the enterprise computing solutions.
About GRFS Grifols S.A.
As a vertically integrated plasma derivative producer, Spain-based Grifols collects plasma and then manufactures and sells plasma-derived products globally. By acquiring Talecris in 2011, Grifols dramatically expanded its plasma-derived product portfolio, and following the firm's Biotest acquisition in April 2022, the biopharma business contributed 84% of sales in 2023. Grifols also has smaller segments including diagnostics (10% of sales) and biosupplies.